Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial

Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    13%
    Check dated 2025-10-05T10:19:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T03:21:05.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2; removed the 'Back to Top' element.
    Difference
    0.8%
    Check dated 2025-09-13T17:36:38.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.8%
    Check dated 2025-09-06T15:05:15.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    9%
    Check dated 2025-08-30T11:48:40.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T04:37:58.000Z thumbnail image

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.